Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

10069786 169204 None 0 Human Functional pEC50 = 5.8 5.8 -147 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 404 7 1 3 5.3 CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL439968 169204 None 0 Human Functional pEC50 = 5.8 5.8 -147 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 404 7 1 3 5.3 CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acsmedchemlett.1c00240
2541 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
2541.0 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
587 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
6907 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
CHEMBL1016 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
DB00796 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
DB13919 786 None 65 Human Functional pEC50 = 4.8 4.8 -8128 10
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O 10.1021/acsmedchemlett.1c00240
2806 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
3937 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
593 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
60846 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
60846.0 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
CHEMBL1069 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
DB00177 3969 None 65 Human Functional pEC50 = 4.8 4.8 -5623 4
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 435 10 2 5 4.2 CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1nnn[nH]1 10.1021/acsmedchemlett.1c00240
44341650 169990 None 0 Human Functional pEC50 = 4.6 4.6 -7 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 406 7 2 3 4.8 CCCCC1NC(=O)C2(CCCC2)N1Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL444060 169990 None 0 Human Functional pEC50 = 4.6 4.6 -7 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 406 7 2 3 4.8 CCCCC1NC(=O)C2(CCCC2)N1Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acsmedchemlett.1c00240
1481 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
3749 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
3749.0 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
589 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
6908 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
CHEMBL1513 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
DB01029 2066 None 66 Human Functional pEC50 = 6.4 6.4 -457 6
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 428 7 1 5 4.8 CCCCC1=NC2(C(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CCCC2 10.1021/acsmedchemlett.1c00240
164613537 185232 None 0 Human Functional pEC50 = 6.3 6.3 -21 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 464 8 1 5 5.4 CCCCC1=NC(C)(c2ccccc2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL4856425 185232 None 0 Human Functional pEC50 = 6.3 6.3 -21 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 464 8 1 5 5.4 CCCCC1=NC(C)(c2ccccc2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
164616479 185422 None 0 Human Functional pEC50 = 5.2 5.2 -16 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 404 7 2 5 3.8 CCCCC1NC(C)(C)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL4859498 185422 None 0 Human Functional pEC50 = 5.2 5.2 -16 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 404 7 2 5 3.8 CCCCC1NC(C)(C)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
44341785 10149 None 0 Human Functional pEC50 = 5.2 5.2 -2 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 438 6 1 3 5.3 O=C(O)c1ccccc1-c1ccc(CN2C(=O)C3(CCCC3)N=C2Cc2ccccc2)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL115771 10149 None 0 Human Functional pEC50 = 5.2 5.2 -2 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 438 6 1 3 5.3 O=C(O)c1ccccc1-c1ccc(CN2C(=O)C3(CCCC3)N=C2Cc2ccccc2)cc1 10.1021/acsmedchemlett.1c00240
67903280 186308 None 0 Human Functional pEC50 = 7.2 7.2 -4 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 430 8 1 5 4.9 CCCCC1=NC(C)(C(C)C)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL4872989 186308 None 0 Human Functional pEC50 = 7.2 7.2 -4 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 430 8 1 5 4.9 CCCCC1=NC(C)(C(C)C)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
164611301 185124 None 0 Human Functional pEC50 = 5.1 5.1 1 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 416 7 1 5 3.9 CCCC[C@H]1N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)C(=O)[C@H]2CCCN21 10.1021/acsmedchemlett.1c00240
CHEMBL4854916 185124 None 0 Human Functional pEC50 = 5.1 5.1 1 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 416 7 1 5 3.9 CCCC[C@H]1N(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)C(=O)[C@H]2CCCN21 10.1021/acsmedchemlett.1c00240
67903275 186629 None 4 Human Functional pEC50 = 5.1 5.1 -257 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 402 7 1 5 4.2 CCCCC1=NC(C)(C)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL4877651 186629 None 4 Human Functional pEC50 = 5.1 5.1 -257 2
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 402 7 1 5 4.2 CCCCC1=NC(C)(C)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.1c00240
44342039 10295 None 0 Human Functional pEC50 = 6.1 6.1 -117 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 418 7 1 3 5.7 CCCCC1=NC2(CCCCC2)C(=O)N1Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acsmedchemlett.1c00240
CHEMBL116170 10295 None 0 Human Functional pEC50 = 6.1 6.1 -117 3
Agonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assayAgonist activity at human BLT2 overexpressed in CHO-K1 cells assessed as accumulation of inositol monophosphate measured after 90 mins by HTRF assay
ChEMBL 418 7 1 3 5.7 CCCCC1=NC2(CCCCC2)C(=O)N1Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acsmedchemlett.1c00240
25174150 9119 None 0 Human Functional pIC50 = 6.8 6.8 -64 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 582 18 2 6 7.3 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccncc3)cc(-c3ccncc3)c2)c1CCC(=O)O 10.1021/jm1001919
CHEMBL1099326 9119 None 0 Human Functional pIC50 = 6.8 6.8 -64 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 582 18 2 6 7.3 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccncc3)cc(-c3ccncc3)c2)c1CCC(=O)O 10.1021/jm1001919
25192022 3355 None 7 Human Functional pIC50 = 6.8 6.8 -21 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 630 18 2 7 8.3 OC(=O)CCc1c(CCCCCCOc2cc(cc(c2)c2ccc3c(c2)OCO3)c2ccsc2)cccc1OCCCC(=O)O 10.1021/jm1001919
6158 3355 None 7 Human Functional pIC50 = 6.8 6.8 -21 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 630 18 2 7 8.3 OC(=O)CCc1c(CCCCCCOc2cc(cc(c2)c2ccc3c(c2)OCO3)c2ccsc2)cccc1OCCCC(=O)O 10.1021/jm1001919
CHEMBL1098560 3355 None 7 Human Functional pIC50 = 6.8 6.8 -21 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 630 18 2 7 8.3 OC(=O)CCc1c(CCCCCCOc2cc(cc(c2)c2ccc3c(c2)OCO3)c2ccsc2)cccc1OCCCC(=O)O 10.1021/jm1001919
25192471 8535 None 0 Human Functional pIC50 = 6.7 6.7 -15 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 642 18 2 6 8.3 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3cccc(F)c3)cc(-c3ccc4c(c3)OCO4)c2)c1CCC(=O)O 10.1021/jm1001919
CHEMBL1094348 8535 None 0 Human Functional pIC50 = 6.7 6.7 -15 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 642 18 2 6 8.3 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3cccc(F)c3)cc(-c3ccc4c(c3)OCO4)c2)c1CCC(=O)O 10.1021/jm1001919
23501721 9123 None 0 Human Functional pIC50 = 5.5 5.5 -316 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 581 18 2 5 7.9 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccccc3)cc(-c3ccccc3)n2)c1CCC(=O)O 10.1021/jm1001919
CHEMBL1099330 9123 None 0 Human Functional pIC50 = 5.5 5.5 -316 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 581 18 2 5 7.9 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccccc3)cc(-c3ccccc3)n2)c1CCC(=O)O 10.1021/jm1001919
25192021 9116 None 0 Human Functional pIC50 = 6.2 6.2 -223 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 580 18 2 4 8.5 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccccc3)cc(-c3ccccc3)c2)c1CCC(=O)O 10.1021/jm1001919
CHEMBL1099323 9116 None 0 Human Functional pIC50 = 6.2 6.2 -223 2
Antagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challengeAntagonist activity at FLAG-tagged human BLT2 receptor expressed in HEK293 cells assessed as inhibition of LTB4-stimulated calcium mobilization preincubated for 10 mins before LTB4 challenge
ChEMBL 580 18 2 4 8.5 O=C(O)CCCOc1cccc(CCCCCCOc2cc(-c3ccccc3)cc(-c3ccccc3)c2)c1CCC(=O)O 10.1021/jm1001919
2487 2368 None 25 Human Functional pEC50 = 6.9 6.9 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
5280492 2368 None 25 Human Functional pEC50 = 6.9 6.9 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
CHEMBL65061 2368 None 25 Human Functional pEC50 = 6.9 6.9 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
DB12961 2368 None 25 Human Functional pEC50 = 6.9 6.9 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
51529932 812 None 25 Human Functional pEC50 = 7.7 7.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 15866883
6161 812 None 25 Human Functional pEC50 = 7.7 7.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 15866883
CHEMBL4637519 812 None 25 Human Functional pEC50 = 7.7 7.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 15866883
5283141 10 None 0 Human Functional pEC50 = 7.7 7.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 280 12 2 2 4.2 CCCCC[C@@H](/C=C/C=C/C/C=C\CCCC(=O)O)O 18378794
6159 10 None 0 Human Functional pEC50 = 7.7 7.7 - 1
UnclassifiedUnclassified
Guide to Pharmacology 280 12 2 2 4.2 CCCCC[C@@H](/C=C/C=C/C/C=C\CCCC(=O)O)O 18378794
6155 1176 None 0 Human Functional pEC50 > 5 5.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
9823886 1176 None 0 Human Functional pEC50 > 5 5.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
CHEMBL301829 1176 None 0 Human Functional pEC50 > 5 5.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
DB13053 1176 None 0 Human Functional pEC50 > 5 5.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
5283130 9 None 0 Human Functional pEC50 > 7.5 7.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 11278893
6160 9 None 0 Human Functional pEC50 > 7.5 7.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 11278893
CHEMBL1742496 9 None 0 Human Functional pEC50 > 7.5 7.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 11278893
3404 12 None 27 Human Functional pEC50 > 7.5 7.5 -107 3
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O 11278893
5283155 12 None 27 Human Functional pEC50 > 7.5 7.5 -107 3
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O 11278893
5508 12 None 27 Human Functional pEC50 > 7.5 7.5 -107 3
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O 11278893
CHEMBL1526258 12 None 27 Human Functional pEC50 > 7.5 7.5 -107 3
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O 11278893
3401 23 None 0 Human Functional pEC50 > 7.5 7.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)O 11278893
5280724 23 None 0 Human Functional pEC50 > 7.5 7.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)O 11278893
CHEMBL594621 23 None 0 Human Functional pEC50 > 7.5 7.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 320 14 2 2 5.2 CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O)O 11278893
6155 1176 None 0 Human Functional pIC50 = 6 6.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
9823886 1176 None 0 Human Functional pIC50 = 6 6.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
CHEMBL301829 1176 None 0 Human Functional pIC50 = 6 6.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
DB13053 1176 None 0 Human Functional pIC50 = 6 6.0 -1318 2
UnclassifiedUnclassified
Guide to Pharmacology 428 4 2 3 5.4 O[C@@H]1[C@H](COc2c1ccc(c2)c1cc(ccc1C(=O)O)C(F)(F)F)Cc1ccccc1 11278893
6162 4146 None 0 Human Functional pIC50 = 6 6.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 432 9 2 2 6.4 OC(=O)CCC/C=C/1\CCCCC1/C=C/C=C/C(C1(CCC1)CC#Cc1ccccc1)O 11278893
9824142 4146 None 0 Human Functional pIC50 = 6 6.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology 432 9 2 2 6.4 OC(=O)CCC/C=C/1\CCCCC1/C=C/C=C/C(C1(CCC1)CC#Cc1ccccc1)O 11278893
3351 2402 None 0 Human Functional pIC50 = 6.6 6.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 360 10 2 6 3.6 CCc1c(OCCCCCC(c2nnn[nH]2)(C)C)cc(cc1C(=O)C)O 11278893
3351 2402 None 0 Human Functional pIC50 = 6.6 6.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 360 10 2 6 3.6 CCc1c(OCCCCCC(c2nnn[nH]2)(C)C)cc(cc1C(=O)C)O 1316967
35025716 2402 None 0 Human Functional pIC50 = 6.6 6.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 360 10 2 6 3.6 CCc1c(OCCCCCC(c2nnn[nH]2)(C)C)cc(cc1C(=O)C)O 11278893
35025716 2402 None 0 Human Functional pIC50 = 6.6 6.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 360 10 2 6 3.6 CCc1c(OCCCCCC(c2nnn[nH]2)(C)C)cc(cc1C(=O)C)O 1316967
2487 2368 None 25 Human Functional pIC50 = 7.6 7.6 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
5280492 2368 None 25 Human Functional pIC50 = 7.6 7.6 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
CHEMBL65061 2368 None 25 Human Functional pIC50 = 7.6 7.6 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
DB12961 2368 None 25 Human Functional pIC50 = 7.6 7.6 -7 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 18378794
5283141 10 None 0 Human Functional pIC50 = 8.6 8.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 280 12 2 2 4.2 CCCCC[C@@H](/C=C/C=C/C/C=C\CCCC(=O)O)O 18378794
6159 10 None 0 Human Functional pIC50 = 8.6 8.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology 280 12 2 2 4.2 CCCCC[C@@H](/C=C/C=C/C/C=C\CCCC(=O)O)O 18378794




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

162655235 180814 None 0 Human Binding pEC50 = 7.0 7.0 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 385 7 1 2 5.4 O=C(O)c1ccccc1-c1ccc(CN(C(=O)CC2CC2)c2ccccc2)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4755611 180814 None 0 Human Binding pEC50 = 7.0 7.0 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 385 7 1 2 5.4 O=C(O)c1ccccc1-c1ccc(CN(C(=O)CC2CC2)c2ccccc2)cc1 10.1021/acs.jmedchem.0c00588
162656403 180941 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 412 8 1 3 5.6 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(C#N)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4757022 180941 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 412 8 1 3 5.6 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(C#N)cc1 10.1021/acs.jmedchem.0c00588
162668994 182713 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 388 8 1 3 5.2 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccncc1 10.1021/acs.jmedchem.0c00588
CHEMBL4788291 182713 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 388 8 1 3 5.2 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccncc1 10.1021/acs.jmedchem.0c00588
162673156 183153 None 0 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 386 8 1 2 5.2 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(N)=O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4794074 183153 None 0 Human Binding pEC50 = 5.8 5.8 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 386 8 1 2 5.2 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(N)=O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162666244 182466 None 0 Human Binding pEC50 = 5.7 5.7 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 464 9 1 4 4.8 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)NS(C)(=O)=O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4784810 182466 None 0 Human Binding pEC50 = 5.7 5.7 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 464 9 1 4 4.8 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)NS(C)(=O)=O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162648208 180023 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 8 1 2 5.5 CCCCN(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(=O)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4746093 180023 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 8 1 2 5.5 CCCCN(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(=O)c1ccccc1 10.1021/acs.jmedchem.0c00588
162660119 181369 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2cc(F)ccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4761937 181369 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2cc(F)ccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162650943 180386 None 0 Human Binding pEC50 = 6.6 6.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 417 9 1 3 5.8 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(OC)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4750707 180386 None 0 Human Binding pEC50 = 6.6 6.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 417 9 1 3 5.8 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(OC)cc1 10.1021/acs.jmedchem.0c00588
126508826 182832 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 411 8 1 4 5.3 CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4789730 182832 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 411 8 1 4 5.3 CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162649472 180183 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 345 5 1 2 4.6 CC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4748013 180183 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 345 5 1 2 4.6 CC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162644087 181876 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 447 7 1 4 5.4 CC(C)CC(=O)N(Cc1ccc(-c2cc(F)ccc2-c2nnn[nH]2)cc1)c1ccc(F)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4777675 181876 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 447 7 1 4 5.4 CC(C)CC(=O)N(Cc1ccc(-c2cc(F)ccc2-c2nnn[nH]2)cc1)c1ccc(F)cc1 10.1021/acs.jmedchem.0c00588
162654469 180688 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 8 1 2 6.1 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(C)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4754213 180688 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 8 1 2 6.1 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(C)cc1 10.1021/acs.jmedchem.0c00588
59738470 180052 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 9 1 2 5.8 CCCCC(=O)N(Cc1ccccc1)Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4746397 180052 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 9 1 2 5.8 CCCCC(=O)N(Cc1ccccc1)Cc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acs.jmedchem.0c00588
162670341 183083 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(F)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4793225 183083 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(F)cc1 10.1021/acs.jmedchem.0c00588
51529932 812 None 25 Human Binding pEC50 = 7.5 7.5 -4 2
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 10.1021/acs.jmedchem.0c00588
6161 812 None 25 Human Binding pEC50 = 7.5 7.5 -4 2
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 10.1021/acs.jmedchem.0c00588
CHEMBL4637519 812 None 25 Human Binding pEC50 = 7.5 7.5 -4 2
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 10.1021/acs.jmedchem.0c00588
162672880 183212 None 0 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 393 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)C1CCCCC1 10.1021/acs.jmedchem.0c00588
CHEMBL4794649 183212 None 0 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 393 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)C1CCCCC1 10.1021/acs.jmedchem.0c00588
162669252 182716 None 0 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 389 8 1 3 4.6 COCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4788324 182716 None 0 Human Binding pEC50 = 5.5 5.5 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 389 8 1 3 4.6 COCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162648232 179862 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 388 8 1 3 5.2 CCCCC(=O)N(Cc1ccc(-c2cnccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4744319 179862 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 388 8 1 3 5.2 CCCCC(=O)N(Cc1ccc(-c2cnccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162657757 181134 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 7 1 2 5.6 CC(C)CC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4759277 181134 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 387 7 1 2 5.6 CC(C)CC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162646830 179717 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 7 1 2 5.8 O=C(O)c1ccccc1-c1ccc(CN(C(=O)Cc2ccccc2)c2ccccc2)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4742371 179717 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 7 1 2 5.8 O=C(O)c1ccccc1-c1ccc(CN(C(=O)Cc2ccccc2)c2ccccc2)cc1 10.1021/acs.jmedchem.0c00588
162665828 182494 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 359 6 1 2 5.0 CCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4785290 182494 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 359 6 1 2 5.0 CCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162647867 179995 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 373 6 1 2 5.2 CC(C)C(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4745803 179995 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 373 6 1 2 5.2 CC(C)C(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162646206 179579 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 415 10 1 2 5.8 CCCCN(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(=O)CCc1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4740860 179579 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 415 10 1 2 5.8 CCCCN(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(=O)CCc1ccccc1 10.1021/acs.jmedchem.0c00588
162653821 180592 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 373 7 1 2 5.4 CCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4753057 180592 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 373 7 1 2 5.4 CCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162670478 183026 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 373 8 1 2 5.6 CCCCC(=O)N(Cc1ccc(-c2ccccc2CO)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4792472 183026 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 373 8 1 2 5.6 CCCCC(=O)N(Cc1ccc(-c2ccccc2CO)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162649840 180229 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 8 1 2 6.4 CCCCC(=O)N(Cc1ccc(-c2ccc(Cl)cc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4748657 180229 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 8 1 2 6.4 CCCCC(=O)N(Cc1ccc(-c2ccc(Cl)cc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162653410 180553 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 8 1 2 6.4 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(Cl)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4752602 180553 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 8 1 2 6.4 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(Cl)cc1 10.1021/acs.jmedchem.0c00588
162662368 182151 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 427 8 1 4 5.4 CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4781057 182151 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 427 8 1 4 5.4 CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162667186 182517 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1F)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4785658 182517 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1F)c1ccccc1 10.1021/acs.jmedchem.0c00588
162655314 180816 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 423 8 1 2 6.1 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(F)c(F)c1 10.1021/acs.jmedchem.0c00588
CHEMBL4755616 180816 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 423 8 1 2 6.1 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(F)c(F)c1 10.1021/acs.jmedchem.0c00588
71254998 181947 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(F)c1 10.1021/acs.jmedchem.0c00588
CHEMBL4778464 181947 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(F)c1 10.1021/acs.jmedchem.0c00588
162653581 180656 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 407 6 1 2 5.9 O=C(O)c1ccccc1-c1ccc(CN(C(=O)c2ccccc2)c2ccccc2)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4753841 180656 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 407 6 1 2 5.9 O=C(O)c1ccccc1-c1ccc(CN(C(=O)c2ccccc2)c2ccccc2)cc1 10.1021/acs.jmedchem.0c00588
118432349 179980 None 0 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 8 0 3 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)OC)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4745616 179980 None 0 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 8 0 3 5.9 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)OC)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162647815 179938 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccc(F)cc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4745083 179938 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 405 8 1 2 5.9 CCCCC(=O)N(Cc1ccc(-c2ccc(F)cc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
162642938 181841 None 0 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 353 8 1 2 5.0 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(C)C 10.1021/acs.jmedchem.0c00588
CHEMBL4777189 181841 None 0 Human Binding pEC50 = 5.2 5.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 353 8 1 2 5.0 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(C)C 10.1021/acs.jmedchem.0c00588
144527428 180991 None 0 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 311 7 2 2 3.9 CCCCC(=O)NCc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4757499 180991 None 0 Human Binding pEC50 = 6.2 6.2 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 311 7 2 2 3.9 CCCCC(=O)NCc1ccc(-c2ccccc2C(=O)O)cc1 10.1021/acs.jmedchem.0c00588
162649935 180099 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 8 1 2 6.4 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(Cl)c1 10.1021/acs.jmedchem.0c00588
CHEMBL4746980 180099 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 421 8 1 2 6.4 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(Cl)c1 10.1021/acs.jmedchem.0c00588
162650402 180199 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 403 8 2 3 5.5 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(O)cc1 10.1021/acs.jmedchem.0c00588
CHEMBL4748248 180199 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 403 8 2 3 5.5 CCCCC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccc(O)cc1 10.1021/acs.jmedchem.0c00588
162666345 182451 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 9 1 2 5.4 CCCCN(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(=O)Cc1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4784561 182451 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 401 9 1 2 5.4 CCCCN(Cc1ccc(-c2ccccc2C(=O)O)cc1)C(=O)Cc1ccccc1 10.1021/acs.jmedchem.0c00588
162648120 180039 None 0 Human Binding pEC50 = 7.0 7.0 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 402 8 2 2 5.6 CCCCNC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
CHEMBL4746259 180039 None 0 Human Binding pEC50 = 7.0 7.0 - 0
Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assayAgonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 90 mins by IP-one assay
ChEMBL 402 8 2 2 5.6 CCCCNC(=O)N(Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1 10.1021/acs.jmedchem.0c00588
122023 50810 None 43 Human Binding pIC50 = 6.8 6.8 - 2
Displacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting methodDisplacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting method
ChEMBL 360 10 2 6 3.6 CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1 10.1021/acsmedchemlett.0c00065
CHEMBL15766 50810 None 43 Human Binding pIC50 = 6.8 6.8 - 2
Displacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting methodDisplacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting method
ChEMBL 360 10 2 6 3.6 CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1 10.1021/acsmedchemlett.0c00065
CHEMBL45460 50810 None 43 Human Binding pIC50 = 6.8 6.8 - 2
Displacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting methodDisplacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting method
ChEMBL 360 10 2 6 3.6 CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1 10.1021/acsmedchemlett.0c00065
51529932 812 None 25 Human Binding pKd = 7.8 7.8 -4 2
Displacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting methodDisplacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting method
ChEMBL 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 10.1021/acsmedchemlett.0c00065
6161 812 None 25 Human Binding pKd = 7.8 7.8 -4 2
Displacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting methodDisplacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting method
ChEMBL 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 10.1021/acsmedchemlett.0c00065
CHEMBL4637519 812 None 25 Human Binding pKd = 7.8 7.8 -4 2
Displacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting methodDisplacement of [3H]LTB4 from HA-epitope tagged human BLT2 expressed in CHOK1 cells incubated for 60 mins by liquid scintillation counting method
ChEMBL 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 10.1021/acsmedchemlett.0c00065
2487 2368 None 25 Human Binding pKd = 7.6 7.6 -31 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 10934230
5280492 2368 None 25 Human Binding pKd = 7.6 7.6 -31 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 10934230
CHEMBL65061 2368 None 25 Human Binding pKd = 7.6 7.6 -31 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 10934230
DB12961 2368 None 25 Human Binding pKd = 7.6 7.6 -31 2
UnclassifiedUnclassified
Guide to Pharmacology 336 14 3 3 4.2 CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)O)O)O 10934230
None 218689 3H-LTB4 0 Human Binding pKi = 6 6.0 -1 2
NoneNone
PDSP KiDatabase 318 14 1 2 5.4 CCCCCC=CCC=CCC=CC=CC(=O)CCCC(=O)O None
None 218690 3H-LTB4 0 Human Binding pKi = 6 6.0 1 2
NoneNone
PDSP KiDatabase 320 14 2 2 5.2 CCCCCC=CCC=CCC=CC=CC(CCCC(=O)O)O None
None 218691 3H-LTB4 0 Human Binding pKi = 6 6.0 10 2
NoneNone
PDSP KiDatabase 320 15 2 2 5.2 C(CCC=CCC=CCC=CCC=CCCCC(=O)O)CCO None
None 218692 3H-LTB4 0 Human Binding pKi = 6 6.0 10 2
NoneNone
PDSP KiDatabase 320 14 2 2 5.2 CCCCCC=CCC=CC=CC(CC=CCCCC(=O)O)O None
None 218693 3H-LTB4 0 Human Binding pKi = 6 6.0 -1 2
NoneNone
PDSP KiDatabase 302 12 1 1 5.7 CCCCCC=CCC=CCC=CCC#CCCCC(=O)O None
2855 4132 3H-LTB4 63 Human Binding pKi = 5 5.0 -7762 6
NoneNone
PDSP KiDatabase 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C None
3322 4132 3H-LTB4 63 Human Binding pKi = 5 5.0 -7762 6
NoneNone
PDSP KiDatabase 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C None
5717 4132 3H-LTB4 63 Human Binding pKi = 5 5.0 -7762 6
NoneNone
PDSP KiDatabase 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C None
5717.0 4132 3H-LTB4 63 Human Binding pKi = 5 5.0 -7762 6
NoneNone
PDSP KiDatabase 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C None
CHEMBL603 4132 3H-LTB4 63 Human Binding pKi = 5 5.0 -7762 6
NoneNone
PDSP KiDatabase 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C None
DB00549 4132 3H-LTB4 63 Human Binding pKi = 5 5.0 -7762 6
NoneNone
PDSP KiDatabase 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C None
None 218695 3H-LTB4 0 Human Binding pKi = 5 5.0 -4365 4
NoneNone
PDSP KiDatabase 473 7 2 3 7.9 CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)S)O None
None 218697 3H-LTB4 0 Human Binding pKi = 5 5.0 -2 2
NoneNone
PDSP KiDatabase 496 20 5 6 3.4 CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N None
None 218700 3H-LTB4 0 Human Binding pKi = 5 5.0 -1 2
NoneNone
PDSP KiDatabase 332 13 0 3 5.3 CCCCCC=CCC=CC=CC=CC1C(O1)CCCC(=O)OC None
132191096 218694 3H-LTB4 0 Human Binding pKi = 5.9 5.9 1 2
NoneNone
PDSP KiDatabase 352 14 4 4 3.1 CCCCCC(C=CC=CC=CC=CC(C(CCCC(=O)O)O)O)O None
None 218687 3H-LTB4 0 Human Binding pKi = 6.8 6.8 6 2
NoneNone
PDSP KiDatabase 318 14 1 2 5.4 CCCCCC=CCC(=O)C=CC=CCC=CCCCC(=O)O None
None 218686 3H-LTB4 0 Human Binding pKi = 6.8 6.8 57 2
NoneNone
PDSP KiDatabase 320 14 2 2 5.2 CCCCCC(C=CC=CCC=CCC=CCCCC(=O)O)O None
None 218684 3H-LTB4 0 Human Binding pKi = 8.6 8.6 -3 2
NoneNone
PDSP KiDatabase 336 14 3 3 4.2 CCCCCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O None
None 218690 3H-LTB4 0 Human Binding pKi = 5.5 5.5 1 2
NoneNone
PDSP KiDatabase 320 14 2 2 5.2 CCCCCC=CCC=CCC=CC=CC(CCCC(=O)O)O None
None 218688 3H-LTB4 0 Human Binding pKi = 5.3 5.3 -218 2
NoneNone
PDSP KiDatabase 361 14 3 4 4.0 CCCCCC=CCC(C=CC1=NC(=CC=C1)CC(CCCCO)O)O None
None 218698 3H-LTB4 0 Human Binding pKi = 5.2 5.2 -2 2
NoneNone
PDSP KiDatabase 439 18 4 5 4.3 CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)O)N None
None 218699 3H-LTB4 0 Human Binding pKi = 5.2 5.2 -1 2
NoneNone
PDSP KiDatabase 568 23 6 7 3.7 CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)O)NC(=O)CCC(C(=O)O)N None
None 218685 3H-LTB4 0 Human Binding pKi = 8.0 8.0 -2 2
NoneNone
PDSP KiDatabase 334 13 3 3 3.9 CCC=CCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O None
None 218696 3H-LTB4 0 Human Binding pKi = 5.1 5.1 -4 2
NoneNone
PDSP KiDatabase 625 25 7 8 2.8 CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N None
51529932 812 None 25 Mouse Binding pKi = 8.5 8.5 4 2
UnclassifiedUnclassified
Guide to Pharmacology 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 15866883
6161 812 None 25 Mouse Binding pKi = 8.5 8.5 4 2
UnclassifiedUnclassified
Guide to Pharmacology 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 15866883
CHEMBL4637519 812 None 25 Mouse Binding pKi = 8.5 8.5 4 2
UnclassifiedUnclassified
Guide to Pharmacology 387 8 1 2 5.8 CCCCC(=O)N(c1ccccc1)Cc1ccc(cc1)c1ccccc1C(=O)O 15866883
OSZAR »